Top

BY Clayton Boldt, Ph.D.

According to the Centers for Disease Control and Prevention, the human papillomavirus is responsible for roughly 33,700 new cancer cases each year, including cancers of the head and neck, the cervix, genitalia, anus and rectum. While there is a safe and effective vaccine available to prevent the majority of these cancers, incidence rates for HPV-related cancers continues to rise, increasing the need for new treatment approaches....

HPV-Related Cancers Moon Shot® co-leader Ann Klopp, M.D., Ph.D., conducts research to improve the impact of immunotherapy on cancers caused by the human papillomavirus.

BY Ron Gilmore

A study at The University of Texas MD Anderson Cancer Center has shed information on a novel oncogenic pathway and points to the use of BET...

BY Ron Gilmore

Just as a driver’s night vision improves by simply cleaning the headlights, scientists at The University of Texas MD Anderson Cancer Center...

BY Clayton R. Boldt, Ph.D.

An international consortium, led in part by clinicians and researchers from The University of Texas MD Anderson Cancer Center, has published a series of best-practice recommendations for conducting clinical trials for neoadjuvant, or pre-surgical, therapies in patients with locally advanced melanoma.

The report, published in Lancet Oncology, provides recommendations for clinical trial design, including patient inclusion criteria...

Metastatic melanoma cells

BY Scott Merville

Combining two types of drugs that, separately, have extended the lives of people with metastatic melanoma has yielded higher response rates...

BY Scott Merville

Nobel Laureate Jim Allison, Ph.D., invented immune checkpoint blockade immunotherapy by blocking the CTLA-4 protein on T cells, freeing those...

BY Jill Russell, Ph.D.

Glioblastoma is the most common, aggressive and deadly form of brain cancer. Median overall survival for primary glioblastoma is 14.6 months...

BY MD Anderson staff

This is the second part of Cancer Frontline’s interview with Padmanee Sharma, M.D., Ph.D., professor of Genitourinary Medical Oncology...

BY MD Anderson staff

In October 2018, the Nobel Prize in Physiology or Medicine was awarded to Jim Allison, Ph.D., chair of Immunology, for his discoveries on...

BY Andrew Olin

A Dream Team assembled by Stand Up To Cancer will receive $8 million in funding to research the use of modified immune cells to fight...